Decades of Innovation
Over the past decades, we have established a robust generics business driven by our core purpose: to enhance access to affordable and innovative medicines and health products for patients and consumers worldwide. From leading the development of biosimilars to pioneering the launch of complex products in key international markets, we have consistently advanced innovation and leveraged our expertise to expand our global reach. Throughout our history, we have been unwavering in our commitment to improving access to affordable medicine, building a strong foundation dedicated to positively impacting the patient’s journey to health. With significant investments in research and development, we have broadened access to prescription and over-the-counter products that are essential to consumers. Our dedication to patient access is further demonstrated through our solid commercial infrastructure, strategic expansions, and meaningful contributions to healthcare philanthropy, including donations to numerous organizations worldwide. Today, we proudly stand as the largest Asian-based pharmaceutical company, distinguished by:
- Our leadership in the number of prescriptions produced.
- Our diverse and comprehensive product portfolio.